Notice of Revision to Full-Year Earnings Guidance for the Fiscal Year Ending March 2027

Overview of Revision to Earnings Outlook

We have revised the full-year earnings guidance for the fiscal year ending March 2027. Net sales are expected to exceed the previous forecast and have been increased from 16,000 million yen to 17,700 million yen. However, operating income, ordinary income, net income attributable to owners of parent, and net income per share are expected to remain at the same levels as the previous forecast, indicating limited improvement in profits. While demand for amino acids and chemical products remains robust, delayed profitability improvement in products for electronic materials and cost increases including raw material prices and logistics expenses are impacting results. Depending on external factors such as geopolitical risks, we may announce further revisions. Numerical figures for the medium-term management plan, with the fiscal year ending March 2027 as the first year, will be published at the Q3 results announcement.

Future Outlook and Risks

Although demand remains strong, continued cost inflation may prevent sales increases from translating into profits. Performance could be significantly affected by geopolitical risks and fluctuations in raw material prices; accordingly, we plan to make additional disclosures depending on future developments.